Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differentiation Induction Therapy for Acute Myelogenous Leukemia

NCT00175812 is registered in ClinicalTrials.gov with University of Bergen as lead sponsor.

NCT NCT00175812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00175812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differentiation Induction Therapy for Acute Myelogenous Leukemia
Lead sponsor
University of Bergen
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2004
Completion date
November 30, 2009
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia